Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Relationship between Helicobacter pylori infection and chronic obstructive pulmonary disease.

Hashemi SH, Nadi E, Hajilooi M, Seif-Rabiei MA, Roustaei U.

Acta Med Iran. 2011;49(11):721-4.

2.

Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease.

Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P, Iliopoulos I, Gourgoulianis K.

Respir Med. 2005 Mar;99(3):279-84.

4.

[Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].

Yang G, Hu F, Jia J.

Zhonghua Yi Xue Za Zhi. 2001 Jun 10;81(11):648-50. Chinese.

PMID:
11798940
5.

[Helicobacter pylori CagA antigen antibodies].

Havlasová J, Bures J, Rejchrt S, Voxová B, Krejsek J.

Cas Lek Cesk. 1998 Jun 29;137(13):404-9. Czech.

PMID:
9748734
6.

[Helicobacter pylori CagA(+) infection in gastric cancer patients].

Ławniczak M, Starzyńska T.

Pol Merkur Lekarski. 2002 Sep;13(75):216-20. Polish.

PMID:
12474574
7.

Abdominal aortic aneurysm and infection with CagA positive strains of Helicobacter pylori.

Nyberg A, Skagius E, Nilsson I, Ljungh A, Henriksson AE.

Scand J Infect Dis. 2008;40(3):204-7. doi: 10.1080/00365540701642153.

PMID:
18274953
8.

Is Helicobacter pylori infection a risk factor for acute coronary syndromes?

Miyazaki M, Babazono A, Kadowaki K, Kato M, Takata T, Une H.

J Infect. 2006 Feb;52(2):86-91.

PMID:
15907342
9.

Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.

Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T.

Am J Gastroenterol. 2005 Jun;100(6):1265-70.

PMID:
15929755
10.

Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests.

Gencer M, Ceylan E, Yildiz Zeyrek F, Aksoy N.

Respiration. 2007;74(2):170-5. Epub 2005 Dec 6.

PMID:
16369121
11.

[Helicobacter pylori genotypes and their association with host's immune response].

Garza-González E, Pérez-Pérez GI, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ.

Rev Gastroenterol Mex. 2002 Jul-Sep;67(3):155-60. Spanish.

PMID:
12653051
12.

Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.

Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.

Immunol Invest. 2007;36(4):371-86.

PMID:
17691020
13.

[Intensification of Helicobacter pylori colonization and serological markers of Helicobacter pylori infection and cytotoxicity in blood].

Bak-Romaniszyn L, Kałuzyński A, Chmiela M, Rudnicka W, Kulig A, Płaneta-Małecka I.

Pol Merkur Lekarski. 2009 May;26(155):407-11. Polish.

PMID:
19606685
14.

Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.

Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.

Int J Med Microbiol. 2006 Aug;296(4-5):223-8.

PMID:
16600680
15.

Helicobacter pylori seroprevalence in patients with chronic bronchitis.

Roussos A, Tsimpoukas F, Anastasakou E, Alepopoulou D, Paizis I, Philippou N.

J Gastroenterol. 2002;37(5):332-5.

PMID:
12051531
16.

Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?

Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O.

Helicobacter. 2004 Jun;9(3):271-7.

PMID:
15165264
18.

Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.

Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, Starzynska T, Marlicz K, Popiela T, Hartwich A, Hahn EG.

J Physiol Pharmacol. 1999 Dec;50(5):857-73.

PMID:
10695565
19.

Does Helicobacter pylori infection play a role in lung cancer?

Ece F, F Hatabay N, Erdal N, Gedik C, Guney C, Aksoy F.

Respir Med. 2005 Oct;99(10):1258-62. Epub 2005 Apr 26.

20.

Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.

Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289.

Supplemental Content

Support Center